Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptorTerumasa Nagase, Takehiko Murakami, Toshihiko Tsukada, et al.
The Journal of Surgical Research|August 6, 2011
The cytostatic effects of lovastatin on ACC-MESO-1 cellsKeisuke Asakura, Yotaro Izumi, Michiko Yamamoto, et al.
Investigational New Drugs|January 12, 2023
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinomaHiroya Manaka, Satoshi Igawa, Michiko Yamamoto, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Bioinformatics research on inter-racial difference in drug metabolism I. Analysis on frequencies of mutant alleles and poor metabolizers on CYP2D6 and CYP2C19Takako Shimizu, Hirohide Ochiai, Fredrik Asell, et al.
Oncology Reports|September 25, 2008
Metabolism of irinotecan and its active metabolite SN-38 by intestinal microflora in ratsMichiko Yamamoto, Akinobu Kurita, Takashi Asahara, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2006
Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancerTomoko Yanaihara, Masanori Yokoba, Sayaka Onoda, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2012
Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancerMaiko Asakuma, Michiko Yamamoto, Mayuko Wada, et al.
Japanese Journal of Clinical Oncology|July 12, 2005
Drug interaction between gefitinib and warfarinSayaka Onoda, Hisashi Mitsufuji, Nobuo Yanase, et al.
Anticancer Research|December 6, 2015
Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910Kouzo Yamada, Haruhiro Saito, Tetsuro Kondo, et al.
International Journal of Clinical Oncology|August 26, 2009
Effect of gefitinib on warfarin antithrombotic activitySusumu Arai, Hisashi Mitsufuji, Yasuto Nishii, et al.
Pageof 6